The role of antirheumatics |
Clinical News
eMediNexus Coverage from: 
The role of antirheumatics

3 Read Comments                

The COVID-19 disease is generally categorised in an initial viral stage and a subsequent immune response phase. The later stage is characterized by hyper inflammation associated with acute respiratory distress syndrome. This warrants the use of many immune modulators and immunosuppressive drugs, which are widely used in rheumatological practice. Evidence suggests Dexamethasone reduces COVID-19 related mortality, interleukin-6 inhibitors reduce the risk of cardiovascular or respiratory organ...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now